A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia

BACKGROUND: In response to the substantial clinical and economic burden of diseases caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) in Tunisia, the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was recently introduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagoubi, Youness, Sfar, Mohamed Tahar, Gomez, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Pneumococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481096/
https://www.ncbi.nlm.nih.gov/pubmed/35703731
http://dx.doi.org/10.1080/21645515.2022.2079305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481096/
https://www.ncbi.nlm.nih.gov/pubmed/35703731
http://dx.doi.org/10.1080/21645515.2022.2079305

Ejemplares similares